Event-free survival according to response. Event-free survival according to: (A) Hematologic response (complete response plus partial response vs stable disease or no response, P = .0001); (B) Organ response (response vs no response, P < .0001); (C) FLCs decreased by more than 50% during therapy or not, P = .019.